Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments

861
61
Favorite

Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments

Seeking Alpha2022-11-13

SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

861

Report

Comment（61）

pandajojo
·2022-11-14
Likr
Reply
1
Report
Tongdadd
·2022-11-14
Claiming credit for the rebound since "previous article" when they have been advocating "Buy" and "Strong Buy" all year, since $114+...... [Facepalm]
Reply
1
Report
andrew123
·2022-11-14
Like
Reply
1
Report
Ljoney
·2022-11-14
Like
Reply
5
Report
Fold Replies
- Yao84:
  Ok
  2022-11-14
  Reply
  Report
- Angela26:
  ok
  2022-11-14
  Reply
  Report
- Ljoney:
  Like
  2022-11-14
  Reply
  Report
Seah CL
·2022-11-14
K
Reply
2
Report
Sephiro
·2022-11-14
Ok
Reply
5
Report
Singlish
·2022-11-14
Good
Reply
5
Report
Fold Replies
- Singlish:
  Good
  2022-11-14
  Reply
  Report
SNeo
·2022-11-14
👍
Reply
4
Report
Fold Replies
- yaozong7:
  Time to get in?
  2022-11-14
  Reply
  Report
Goupppppppp
·2022-11-14
Ok
Reply
3
Report
Fold Replies
- kksuen:
  k
  2022-11-14
  Reply
  Report
AS78
·2022-11-14
[What]
Reply
4
Report
AJAJ
·2022-11-14
Ok
Reply
3
Report
phantom74
·2022-11-14
like
Reply
4
Report
Fold Replies
- andrewtm22:
  ok
  2022-11-14
  Reply
  Report
- AJAJ:
  Ok
  2022-11-14
  Reply
  Report
Bodoh
·2022-11-14
Oh?
Reply
1
Report
Fold Replies
- ArcherWG:
  Okay
  2022-11-14
  Reply
  Report
Khoo18
·2022-11-14
K
Reply
2
Report
Fold Replies
- Chitz:
  yes
  2022-11-14
  Reply
  Report
Black83black
·2022-11-14
👌
Reply
1
Report
Fold Replies
- Black83black:
  👍 🏻
  2022-11-14
  Reply
  Report
YJ Lee
·2022-11-14
Ok
Reply
2
Report
ML808
·2022-11-14
Great
Reply
4
Report
Fold Replies
- ML808:
  yes
  2022-11-14
  Reply
  Report
sunflower19
·2022-11-14
Ok
Reply
4
Report
Fold Replies
- Khoo18:
  k
  2022-11-14
  Reply
  Report
- k1wong:
  k
  2022-11-14
  Reply
  Report
Tiongwee
·2022-11-14
Like
Reply
5
Report
Fold Replies
- Saintrade:
  Ok
  2022-11-14
  Reply
  Report
逢場作戲又一日
·2022-11-14
Great
Reply
5
Report
Fold Replies
- Tiongwee:
  Ok
  2022-11-14
  Reply
  Report
- fabio:
  😂
  2022-11-14
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2282457893?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-11-13 09:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2282457893","market":"us","top_or_hot":-1,"title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","media":"Seeking Alpha","content":"<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Source Link</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09988","symbol_name":"阿里巴巴-W","start_time":0,"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","article_id":"2282457893","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","pubTimestamp":1668301809,"sourceInfo":null,"weMediaInfo":null,"summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"translate_title":"阿里巴巴-SW：零COVID政策的完善提升了市场情绪","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BABA":1,"09988":0.6},"content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9969154030,"gmtCreate":1668389356920,"gmtModify":1676538048337,"author":{"id":"3578965435978206","authorId":"3578965435978206","name":"pandajojo","avatar":"https://static.tigerbbs.com/7efe44a2514d987c5a8b342b85d6f229","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3578965435978206","idStr":"3578965435978206"},"htmlText":"Likr","listText":"Likr","text":"Likr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969154030","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969116977,"gmtCreate":1668384769400,"gmtModify":1676538046960,"author":{"id":"3563665738915585","authorId":"3563665738915585","name":"Tongdadd","avatar":"https://static.tigerbbs.com/79e519b2023d6e7e3b68e295f81f3e8e","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":6,"crmLevelSwitch":1,"authorIdStr":"3563665738915585","idStr":"3563665738915585"},"htmlText":"Claiming credit for the rebound since \"previous article\" when they have been advocating&nbsp;\"Buy\" and \"Strong Buy\" all year, since $114+......&nbsp;[Facepalm]&nbsp;","listText":"Claiming credit for the rebound since \"previous article\" when they have been advocating&nbsp;\"Buy\" and \"Strong Buy\" all year, since $114+......&nbsp;[Facepalm]&nbsp;","text":"Claiming credit for the rebound since \"previous article\" when they have been advocating \"Buy\" and \"Strong Buy\" all year, since $114+...... [Facepalm]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969116977","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969377687,"gmtCreate":1668381398450,"gmtModify":1676538045921,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://community-static.tradeup.com/news/f2a1eaba26272212d42018e60e78b422","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3576260758860416","idStr":"3576260758860416"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969377687","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969345516,"gmtCreate":1668380258335,"gmtModify":1676538045593,"author":{"id":"3581591015314710","authorId":"3581591015314710","name":"Ljoney","avatar":"https://static.tigerbbs.com/8376cac12c1b661feac4d507eb1379e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581591015314710","idStr":"3581591015314710"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9969345516","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104800158,"gmtCreate":1668435692839,"gmtModify":1668435706329,"authorId":3578997581123464,"author":{"id":3578997581123464,"idStr":"3578997581123464","authorId":3578997581123464,"name":"Yao84","avatar":"https://static.tigerbbs.com/5e30432f9f4a2555514d757fdb9c4f0d","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.30","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969345516,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"},{"id":104786835,"gmtCreate":1668380345022,"gmtModify":1668380358023,"authorId":3575785954938833,"author":{"id":3575785954938833,"idStr":"3575785954938833","authorId":3575785954938833,"name":"Angela26","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969345516,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":104786823,"gmtCreate":1668380314664,"gmtModify":1668380327398,"authorId":3581591015314710,"author":{"id":3581591015314710,"idStr":"3581591015314710","authorId":3581591015314710,"name":"Ljoney","avatar":"https://static.tigerbbs.com/8376cac12c1b661feac4d507eb1379e4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969345516,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Like</span>","text":"<span class=\"s1\">Like</span>","html":"<span class=\"s1\">Like</span>"}],"langContent":"EN"},{"id":9969346820,"gmtCreate":1668380002761,"gmtModify":1676538045509,"author":{"id":"4102135564535180","authorId":"4102135564535180","name":"Seah CL","avatar":"https://community-static.tradeup.com/news/970bca7b04e85a42a2c8eabed7ec96d0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"4102135564535180","idStr":"4102135564535180"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969346820","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969348874,"gmtCreate":1668379847698,"gmtModify":1676538045485,"author":{"id":"4102856944715880","authorId":"4102856944715880","name":"Sephiro","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4102856944715880","idStr":"4102856944715880"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969348874","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969349467,"gmtCreate":1668379438260,"gmtModify":1676538045416,"author":{"id":"3581682705103576","authorId":"3581682705103576","name":"Singlish","avatar":"https://static.tigerbbs.com/5543d796a986077e2fa4a07d4fb4d478","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3581682705103576","idStr":"3581682705103576"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969349467","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786630,"gmtCreate":1668379488023,"gmtModify":1668379501663,"authorId":3581682705103576,"author":{"id":3581682705103576,"idStr":"3581682705103576","authorId":3581682705103576,"name":"Singlish","avatar":"https://static.tigerbbs.com/5543d796a986077e2fa4a07d4fb4d478","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969349467,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Good</span>","text":"<span class=\"s1\">Good</span>","html":"<span class=\"s1\">Good</span>"}],"langContent":"EN"},{"id":9969340650,"gmtCreate":1668379122671,"gmtModify":1676538045377,"author":{"id":"4112071922817752","authorId":"4112071922817752","name":"SNeo","avatar":"https://community-static.tradeup.com/news/d5b48d982c4246e1c1d0400e42ad5e32","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"4112071922817752","idStr":"4112071922817752"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969340650","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786678,"gmtCreate":1668379701016,"gmtModify":1668379714143,"authorId":3553658931361428,"author":{"id":3553658931361428,"idStr":"3553658931361428","authorId":3553658931361428,"name":"yaozong7","avatar":"https://community-static.tradeup.com/news/0db82c58fe151c6056334e54bf8ceeee","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969340650,"type":1,"supId":0,"prevId":0,"content":"Time to get in?","text":"Time to get in?","html":"Time to get in?"}],"langContent":"EN"},{"id":9969357549,"gmtCreate":1668379024681,"gmtModify":1676538045361,"author":{"id":"3578690837330197","authorId":"3578690837330197","name":"Goupppppppp","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578690837330197","idStr":"3578690837330197"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969357549","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786682,"gmtCreate":1668379718799,"gmtModify":1668379732876,"authorId":3557629001242050,"author":{"id":3557629001242050,"idStr":"3557629001242050","authorId":3557629001242050,"name":"kksuen","avatar":"https://static.tigerbbs.com/e1eb0ceb998a78cefb82c2f66d2addb1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969357549,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"}],"langContent":"EN"},{"id":9969354523,"gmtCreate":1668378891562,"gmtModify":1676538045325,"author":{"id":"3554958921608603","authorId":"3554958921608603","name":"AS78","avatar":"https://community-static.tradeup.com/news/d392d10a42f496e319268418e7602694","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3554958921608603","idStr":"3554958921608603"},"htmlText":"[What]&nbsp;","listText":"[What]&nbsp;","text":"[What]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969354523","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969354981,"gmtCreate":1668378734943,"gmtModify":1676538045308,"author":{"id":"3581823222182692","authorId":"3581823222182692","name":"AJAJ","avatar":"https://static.tigerbbs.com/d39956ed0487a0f393611b7d94da0db0","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581823222182692","idStr":"3581823222182692"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969354981","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969327797,"gmtCreate":1668377603119,"gmtModify":1676538045100,"author":{"id":"3570342809089528","authorId":"3570342809089528","name":"phantom74","avatar":"https://static.tigerbbs.com/c87ef2af41b8696be86cceafb5b5723d","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3570342809089528","idStr":"3570342809089528"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9969327797","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786756,"gmtCreate":1668380102000,"gmtModify":1668380115794,"authorId":3568408942405951,"author":{"id":3568408942405951,"idStr":"3568408942405951","authorId":3568408942405951,"name":"andrewtm22","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969327797,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":104786509,"gmtCreate":1668378745298,"gmtModify":1668378758511,"authorId":3581823222182692,"author":{"id":3581823222182692,"idStr":"3581823222182692","authorId":3581823222182692,"name":"AJAJ","avatar":"https://static.tigerbbs.com/d39956ed0487a0f393611b7d94da0db0","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969327797,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"}],"langContent":"EN"},{"id":9969325781,"gmtCreate":1668377020444,"gmtModify":1676538045043,"author":{"id":"3559859558754319","authorId":"3559859558754319","name":"Bodoh","avatar":"https://static.tigerbbs.com/349218ea2852130ca86ce660b4aa2d59","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3559859558754319","idStr":"3559859558754319"},"htmlText":"Oh?","listText":"Oh?","text":"Oh?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969325781","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786545,"gmtCreate":1668378983712,"gmtModify":1668378996870,"authorId":3581837121803380,"author":{"id":3581837121803380,"idStr":"3581837121803380","authorId":3581837121803380,"name":"ArcherWG","avatar":"https://community-static.tradeup.com/news/38e40c44fababa6849ceb15dfe8931a3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969325781,"type":1,"supId":0,"prevId":0,"content":"<u>Okay</u>","text":"<u>Okay</u>","html":"<u>Okay</u>"}],"langContent":"EN"},{"id":9969325266,"gmtCreate":1668376922555,"gmtModify":1676538045035,"author":{"id":"3586514899418238","authorId":"3586514899418238","name":"Khoo18","avatar":"https://static.tigerbbs.com/a895cde27a6f60014dacbbc8853a5e1e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586514899418238","idStr":"3586514899418238"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969325266","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786158,"gmtCreate":1668377406300,"gmtModify":1668377418888,"authorId":3574934277926519,"author":{"id":3574934277926519,"idStr":"3574934277926519","authorId":3574934277926519,"name":"Chitz","avatar":"https://static.tigerbbs.com/988984eee397d7e772b978815d9b162e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969325266,"type":1,"supId":0,"prevId":0,"content":"<u>yes</u>","text":"<u>yes</u>","html":"<u>yes</u>"}],"langContent":"EN"},{"id":9969326223,"gmtCreate":1668376374062,"gmtModify":1676538044980,"author":{"id":"3576542985729070","authorId":"3576542985729070","name":"Black83black","avatar":"https://community-static.tradeup.com/news/dc5940f5fefb9966b35345e7dd1aa9b8","vip":1,"hat":"https://static.tigerbbs.com/6444b4970948c1077534c593eccd6d16","crmLevel":7,"crmLevelSwitch":1,"authorIdStr":"3576542985729070","idStr":"3576542985729070"},"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969326223","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786034,"gmtCreate":1668376384014,"gmtModify":1668376396827,"authorId":3576542985729070,"author":{"id":3576542985729070,"idStr":"3576542985729070","authorId":3576542985729070,"name":"Black83black","avatar":"https://community-static.tradeup.com/news/dc5940f5fefb9966b35345e7dd1aa9b8","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.01","exceedPercentage":"93.02%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":7,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969326223,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">👍 🏻</span>","text":"<span class=\"s1\">👍 🏻</span>","html":"<span class=\"s1\">👍 🏻</span>"}],"langContent":"EN"},{"id":9969321149,"gmtCreate":1668375846282,"gmtModify":1676538044919,"author":{"id":"4108816210230400","authorId":"4108816210230400","name":"YJ Lee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4108816210230400","idStr":"4108816210230400"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9969321149","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9969365060,"gmtCreate":1668373678850,"gmtModify":1676538044735,"author":{"id":"3582359360248748","authorId":"3582359360248748","name":"ML808","avatar":"https://static.tigerbbs.com/f601c68849ffbac8b7679f40f1471368","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3582359360248748","idStr":"3582359360248748"},"htmlText":"Great&nbsp;","listText":"Great&nbsp;","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969365060","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104785786,"gmtCreate":1668373688708,"gmtModify":1668373701511,"authorId":3582359360248748,"author":{"id":3582359360248748,"idStr":"3582359360248748","authorId":3582359360248748,"name":"ML808","avatar":"https://static.tigerbbs.com/f601c68849ffbac8b7679f40f1471368","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969365060,"type":1,"supId":0,"prevId":0,"content":"<u>yes</u>","text":"<u>yes</u>","html":"<u>yes</u>"}],"langContent":"EN"},{"id":9969362000,"gmtCreate":1668373558901,"gmtModify":1676538044708,"author":{"id":"4106158448616940","authorId":"4106158448616940","name":"sunflower19","avatar":"https://static.itradeup.com/news/f2b81b440927ad671cd053689e3da178","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4106158448616940","idStr":"4106158448616940"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9969362000","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104786105,"gmtCreate":1668376918801,"gmtModify":1668376932125,"authorId":3586514899418238,"author":{"id":3586514899418238,"idStr":"3586514899418238","authorId":3586514899418238,"name":"Khoo18","avatar":"https://static.tigerbbs.com/a895cde27a6f60014dacbbc8853a5e1e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969362000,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"},{"id":104785886,"gmtCreate":1668375014500,"gmtModify":1668375026964,"authorId":3574996050082067,"author":{"id":3574996050082067,"idStr":"3574996050082067","authorId":3574996050082067,"name":"k1wong","avatar":"https://community-static.tradeup.com/news/677b37ef7f68f9ac2e51ca5f6ad6ef5e","vip":1,"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969362000,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"}],"langContent":"EN"},{"id":9969363016,"gmtCreate":1668362460735,"gmtModify":1676538044590,"author":{"id":"3573775111920367","authorId":"3573775111920367","name":"Tiongwee","avatar":"https://static.tigerbbs.com/e90910e406e67c77f42e225b16b69020","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573775111920367","idStr":"3573775111920367"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9969363016","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104785859,"gmtCreate":1668374521380,"gmtModify":1668374534870,"authorId":3577131990335289,"author":{"id":3577131990335289,"idStr":"3577131990335289","authorId":3577131990335289,"name":"Saintrade","avatar":"https://static.tigerbbs.com/0586ed865bb515fc4dd23fea4fa2590d","vip":1,"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969363016,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"}],"langContent":"EN"},{"id":9969387470,"gmtCreate":1668359721990,"gmtModify":1676538044527,"author":{"id":"3555043402922696","authorId":"3555043402922696","name":"逢場作戲又一日","avatar":"https://community-static.tradeup.com/news/6a5fbf2ceb7c7ee0399d41e6348dadf7","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3555043402922696","idStr":"3555043402922696"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9969387470","repostId":2282457893,"repostType":4,"repost":{"id":"2282457893","pubTimestamp":1668301809,"share":"https://ttm.financial/m/news/2282457893?lang=&edition=fundamental","pubTime":"2022-11-13 09:10","market":"us","language":"en","title":"Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments","url":"https://stock-news.laohu8.com/highlight/detail?id=2282457893","media":"Seeking Alpha","summary":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales fi","content":"<html><head></head><body><h2>Summary</h2><ul><li>Alibaba heads into its FQ2&#39;23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles&#39; Day (11.11) sales event.</li><li>We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.</li><li>At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.</li><li>Maintain Strong Buy with a PT of $90.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99fd8bfbb6e746ad97e8ae396d55f7fb\" tg-width=\"750\" tg-height=\"500\" width=\"100%\" height=\"auto\"/><span>Robert Way</span></p><p><i>This article is written by </i><i>JR Research</i><i> for reference only. Please note the risks.</i></p><h2>Thesis</h2><p>Alibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2&#39;23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles&#39; Day (11.11) sales event for the first time.</p><p>Alibaba reported that its 11.11 event &#34;[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.&#34; Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021&#39;s 11.11 event.</p><p>Therefore, all eyes will be on CEO Daniel Zhang &amp; team on November 17, as Bloomberg had reported earlier that Alibaba&#39;s 11.11 event &#34;may suffer a decline unprecedented in the event&#39;s 14-year history.&#34;</p><p>Despite that, BABA has outperformed the S&amp;P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA&#39;s recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.</p><p>We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China&#39;s political risks, BABA&#39;s price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA&#39;s reward/risk profile remains attractive.</p><p>Maintain Strong Buy with a medium-term price target (PT) of $90.</p><h2>Refinement Of China&#39;s COVID Policy Is Good Progress</h2><p>China lifted the market&#39;s sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for &#34;more decisive&#34; measures, as Bloomberg reported:</p><blockquote>In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - Bloomberg</blockquote><p>Therefore the &#34;20 measures&#34; rolled out by China&#39;s State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China&#39;s COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.</p><p>Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.</p><p>Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.</p><h2>What&#39;s Next For Alibaba?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ddc437479ec434895135417dc6411936\" tg-width=\"640\" tg-height=\"396\" width=\"100%\" height=\"auto\"/><span>Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&amp;P Cap IQ)</span></p><p>Therefore, we think the thesis for a bottoming in Alibaba&#39;s revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.</p><p>China&#39;s hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China&#39;s trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.</p><p>Furthermore, China&#39;s producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China&#39;s economy, likely spurring policymakers to act more urgently to arrest China&#39;s economic malaise.</p><p>Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the &#34;second quarter of [2023].&#34; Therefore, we believe Wall Street&#39;s estimates have been predicated on such a possibility.</p><p>Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.</p><h2>Is BABA Stock A Buy, Sell, Or Hold?</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b99a8e7fe43e4b72d7e31dbf093f969e\" tg-width=\"640\" tg-height=\"340\" width=\"100%\" height=\"auto\"/><span>BABA price chart (weekly) (TradingView)</span></p><p>We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.</p><p>Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.</p><p>Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.</p><p>With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.</p><p><i>Maintain Strong Buy with a medium-term PT of $90.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Refinement Of Zero COVID Policy Lifts Market Sentiments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-13 09:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively ...</p>\n\n<a href=\"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4556789-alibaba-refinement-zero-covid-policy-lifts-market-sentiments","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2282457893","content_text":"SummaryAlibaba heads into its FQ2'23 earnings release on November 17 without disclosing its sales figures for its recently concluded Singles' Day (11.11) sales event.We discuss why even a relatively weak FQ2 earnings release should not impact the potential re-rating of BABA as China has started to refine its zero COVID policy.At these levels, the reward/risk setup pointing to the upside remains attractive, with an earlier reopening likely spurring further buying momentum.Maintain Strong Buy with a PT of $90.Robert WayThis article is written by JR Research for reference only. Please note the risks.ThesisAlibaba Group Holding Limited (NYSE:BABA) heads into its highly-anticipated FQ2'23 (quarter ended September 30) earnings release on November 17, even as it held back from reporting actual sales figures for its 2022 Singles' Day (11.11) sales event for the first time.Alibaba reported that its 11.11 event \"[delivered GMV] for brands in line with [2021] despite economic and COVID-related headwinds.\" Notably, Alibaba reported a gross merchandise value (GMV) of RMB540.3B for 2021's 11.11 event.Therefore, all eyes will be on CEO Daniel Zhang & team on November 17, as Bloomberg had reported earlier that Alibaba's 11.11 event \"may suffer a decline unprecedented in the event's 14-year history.\"Despite that, BABA has outperformed the S&P 500 (SPX) (SP500) since we upgraded it to Strong Buy in our previous article. Moreover, BABA's recent recovery was bolstered by the anticipation of a progressive easing of COVID policy. As such, the positive reaction by the market was not surprising.We discuss why we glean that the mean reversion move for BABA remains attractive at the current levels. Despite the massive pessimism seen as investors further de-rated China's political risks, BABA's price action remains constructive. Coupled with a well-beaten-down valuation in line with its Hong Kong tech peers, we assess that BABA's reward/risk profile remains attractive.Maintain Strong Buy with a medium-term price target (PT) of $90.Refinement Of China's COVID Policy Is Good ProgressChina lifted the market's sentiments last week as the newly installed Politburo Standing Committee (PSC) highlighted the need for \"more decisive\" measures, as Bloomberg reported:In a meeting of the new Politburo Standing Committee, the members called for more decisive measures to curb the spread of the virus so as to resume normal life and production as soon as possible, according to the Xinhua News Agency. - BloombergTherefore the \"20 measures\" rolled out by China's State Council and National Health Commission that reduced centralized quarantine time and flight suspension penalties were not expected by the market. Moreover, it occurred while COVID cases continued rising. Bloomberg reported that China's COVID cases increased to 11.3K on Friday (November 11), breaking above 10K for the first time since April on Thursday.Furthermore, some cities actually reduced mass testing despite the rising cases. Hence, we believe the odds for a progressive ending in COVID zero are increasingly likely.Still, investors should not rule out Beijing tightening its COVID policy again if COVID cases continue to rise higher, or even spike. China has maintained that the recent measures do not indicate that China has moved to living with the virus. Stamping out COVID expeditiously remains the guiding principle of its policy measures. As such, investors should expect near-term downside volatility if Beijing tightens further.What's Next For Alibaba?Alibaba Revenue change % and Adjusted EBITDA change % consensus estimates (S&P Cap IQ)Therefore, we think the thesis for a bottoming in Alibaba's revenue and profitability growth by FY23 (year ending March 2023) is increasingly likely.China's hand has likely been forced by the worsening global macroeconomic headwinds that has added significant stress to its domestic malaise. Moreover, China's trade surplus weakened further in October as exports fell for the first time since May 2020, down 0.3% YoY.Furthermore, China's producer price index (PPI) declined 1.3% YoY in October, down for the first time in over two years. Hence, the disinflation signals are building up in China's economy, likely spurring policymakers to act more urgently to arrest China's economic malaise.Therefore, while Alibaba may report a relatively tepid or even lower-than-project FQ2 earnings release, the market is already looking ahead. While still early, Goldman Sachs had previously highlighted that it expected a reopening in the \"second quarter of [2023].\" Therefore, we believe Wall Street's estimates have been predicated on such a possibility.Given that China has already started to set the wheels in motion, despite the surge in COVID cases, we believe the reward/risk for an earlier exit is likely pointing to the upside.Is BABA Stock A Buy, Sell, Or Hold?BABA price chart (weekly) (TradingView)We emphasized in our previous update that BABA has two robust support zones that could see buyers defending vigorously against further selling pressure.Therefore, even after the market forced sellers to give up after it broke below its March lows, buyers came in to defend its October 2015 levels ($57). That level appears to have been defended resolutely, which suggests that the market pulled the rug on weak holders who added the dips in March/May 2022.Notwithstanding, we still need BABA to retake its March level and sit above it decisively for our thesis of a mean-reversion setup toward the $95 level to play out accordingly.With China moving progressively away from its zero COVID strategy, we believe the potential for Alibaba to outperform the markedly downgraded consensus projections is looking increasingly likely.Maintain Strong Buy with a medium-term PT of $90.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104785688,"gmtCreate":1668362472328,"gmtModify":1668362486235,"authorId":3573775111920367,"author":{"id":3573775111920367,"idStr":"3573775111920367","authorId":3573775111920367,"name":"Tiongwee","avatar":"https://static.tigerbbs.com/e90910e406e67c77f42e225b16b69020","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969387470,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"},{"id":104785656,"gmtCreate":1668360949226,"gmtModify":1668360961971,"authorId":3555261138218608,"author":{"id":3555261138218608,"idStr":"3555261138218608","authorId":3555261138218608,"name":"fabio","avatar":"https://static.tigerbbs.com/8da22244b65eeb511fac3b0633934760","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9969387470,"type":1,"supId":0,"prevId":0,"content":"😂","text":"😂","html":"😂"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":861,"commentSize":61,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}